专利检索 ap:("Oyster Point Pharma, Inc.") AND inv:"Timothy J. Cuthbertson" 第 1 页

1.

发明授权
Salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine 有权

公开(公告)号：US10421745B2

公开(公告)日：2019-09-24

申请号：US15962982

申请日：2018-04-25

申请人： Oyster Point Pharma, Inc.

发明人： Srinivasa Rao Akireddy , Balwinder Singh Bhatti , Timothy J. Cuthbertson , Gary Maurice Dull , Craig Harrison Miller , Joseph Pike Mitchener, Jr. , Julio A. Munoz , Pieter Albert Otten

IPC分类号： C07D403/06 , C07C59/255 , A61K31/4025 , C07C59/265

摘要： The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.

2.

发明申请
SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE 有权

公开(公告)号：US20170260167A1

公开(公告)日：2017-09-14

申请号：US15354832

申请日：2016-11-17

申请人： Oyster Point Pharma, Inc.

发明人： Srinivasa Rao Akireddy , Balwinder Singh Bhatti , Timothy J. Cuthbertson , Gary Maurice Dull , Craig Harrison Miller , Joseph Pike Mitchener, JR. , Julio A. Munoz , Pieter Albert Otten

IPC分类号： C07D403/06 , C07C59/255 , C07C59/265 , A61K31/4025

CPC分类号： C07D403/06 , A61K31/4025 , C07C59/255 , C07C59/265

摘要： The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.

3.

发明授权
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine 有权

公开(公告)号：US11542253B2

公开(公告)日：2023-01-03

申请号：US17144884

申请日：2021-01-08

申请人： Oyster Point Pharma, Inc.

发明人： Srinivasa Rao Akireddy , Balwinder Singh Bhatti , Timothy J. Cuthbertson , Gary Maurice Dull , Craig Harrison Miller , Joseph Pike Mitchener, Jr. , Julio A. Munoz , Pieter Albert Otten

IPC分类号： C07D403/06 , C07C59/255 , A61K31/4025 , C07C59/265

摘要： The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.

4.

发明授权
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine 有权

公开(公告)号：US10919879B2

公开(公告)日：2021-02-16

申请号：US16541033

申请日：2019-08-14

申请人： Oyster Point Pharma, Inc.

发明人： Srinivasa Rao Akireddy , Balwinder Singh Bhatti , Timothy J. Cuthbertson , Gary Maurice Dull , Craig Harrison Miller , Joseph Pike Mitchener, Jr. , Julio A. Munoz , Pieter Albert Otten

IPC分类号： C07D403/06 , C07C59/255 , A61K31/4025 , C07C59/265

摘要： The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.

5.

发明授权
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine 有权

公开(公告)号：US09981949B2

公开(公告)日：2018-05-29

申请号：US15354832

申请日：2016-11-17

申请人： Oyster Point Pharma, Inc.

发明人： Srinivasa Rao Akireddy , Balwinder Singh Bhatti , Timothy J. Cuthbertson , Gary Maurice Dull , Craig Harrison Miller , Joseph Pike Mitchener, Jr. , Julio A. Munoz , Pieter Albert Otten

IPC分类号： C07D403/06 , C07C59/265 , A61K31/4025 , C07C59/255

CPC分类号： C07D403/06 , A61K31/4025 , C07C59/255 , C07C59/265

摘要： The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.